Beijing Anzhen Hospital
Clinical trials sponsored by Beijing Anzhen Hospital, explained in plain language.
-
Heart Patients' genes may guide safer, more effective clot prevention
Disease control OngoingThis study looked at whether using a genetic test to choose blood thinners can reduce heart attacks, strokes, and death in people who have had a heart stent placed. About 4,000 adults with stable angina or acute coronary syndrome were given either clopidogrel or ticagrelor based …
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
AI could help heart surgery patients get the right Anti-Inflammatory drug
Knowledge-focused OngoingThis study looks at data from 10,000 heart surgery patients to build an AI tool that helps doctors decide who will benefit from a drug called ulinastatin. The drug may reduce inflammation and complications after surgery, but it doesn't work for everyone. The goal is to match the …
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:13 UTC
-
AI assistant could revolutionize heart attack care in china
Knowledge-focused OngoingThis study is testing a new AI-powered decision support system to help doctors treat patients having a heart attack. The goal is to reduce delays in diagnosis and treatment, and improve patient outcomes. The study will involve 15,000 participants across multiple hospitals in Chin…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:01 UTC